Generic name: HYDROCODONE BITARTRATE 5mg, ACETAMINOPHEN 325mg
Dosage form: tablet
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
Important Dosage and Administration Instructions
Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see WARNINGS].
Initiate the dosing regimen for each patient individually, taking into account the patient's severity of pain, patient response, prior analgesic treatment experience, and risk factors for addiction, abuse, and misuse [see WARNINGS].
Follow patients closely for respiratory depression, especially within the first 24-72 hours of initiating therapy and following dosage increases with NORCO® and adjust the dosage accordingly [see WARNINGS].
Initiating Treatment with NORCO®
|NORCO® 5/325||The usual adult dosage is one or two tablets every four to six hours as needed for pain. The total daily dosage should not exceed 8 tablets.|
|The usual adult dosage is one tablet every four to six hours as needed for pain. The total daily dosage should not exceed 6 tablets.|
Conversion from Other Opioids to NORCO®
There is inter-patient variability in the potency of opioid drugs and opioid formulations. Therefore, a conservative approach is advised when determining the total daily dosage of NORCO®. It is safer to underestimate a patient’s 24-hour NORCO® dosage than to overestimate the 24-hour NORCO® dosage and manage an adverse reaction due to overdose.
Conversion from NORCO® to Extended-Release Hydrocodone
The relative bioavailability of hydrocodone from NORCO® compared to extended-release hydrocodone products is unknown, so conversion to extended-release products must be accompanied by close observation for signs of excessive sedation and respiratory depression.
Titration and Maintenance of Therapy
Individually titrate NORCO® to a dose that provides adequate analgesia and minimizes adverse reactions. Continually reevaluate patients receiving NORCO® to assess the maintenance of pain control and the relative incidence of adverse reactions, as well as monitoring for the development of addiction, abuse, or misuse [see WARNINGS]. Frequent communication is important among the prescriber, other members of the healthcare team, the patient, and the caregiver/family during periods of changing analgesic requirements, including initial titration.
If the level of pain increases after dosage stabilization, attempt to identify the source of increased pain before increasing the NORCO® dosage. If unacceptable opioid-related adverse reactions are observed, consider reducing the dosage. Adjust the dosage to obtain an appropriate balance between management of pain and opioid-related adverse reactions.
Discontinuation of NORCO®
When a patient who has been taking NORCO® regularly and may be physically dependent no longer requires therapy with NORCO®, taper the dose gradually, by 25% to 50% every 2 to 4 days, while monitoring carefully for signs and symptoms of withdrawal. If the patient develops these signs or symptoms, raise the dose to the previous level and taper more slowly, either by increasing the interval between decreases, decreasing the amount of change in dose, or both. Do not abruptly discontinue NORCO® in a physically-dependent patient [see WARNINGS, DRUG ABUSE AND DEPENDENCE].
More about Norco (acetaminophen / hydrocodone)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 211 Reviews – Add your own review/rating
- Drug class: narcotic analgesic combinations